Upgrade to SI Premium - Free Trial

Biogen (BIIB) Reports Interferon Beta Treatments, Including PLEGRIDY (peginterferon beta-1a) & AVONEX (interferon beta-1a), Positive Receive Positive CHMP Opinion

September 23, 2019 5:54 AM
Biogen Inc. (NASDAQ: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP), part of the of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles